Clinical Trials Directory

Trials / Completed

CompletedNCT04417400

Evaluation of Medicines Use Review in Slovenia

Benefits of Medicines Use Review Service in Slovenia: a Randomized Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
169 (actual)
Sponsor
Mitja Kos · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Medicines Use Review service (PUZ) has been officially introduced in Slovenian pharmacy practice in 2015 and has been offered to pharmacy customers by pharmacist, certified to provide the service. Patients can to talk to a pharmacist and discuss their medicines, how they use it and any issues or question they might have. We designed a study to evaluate how Medicines Use Review (PUZ) work and how it is reaching the set objectives. The objectives of the PUZ service are to address actual patient medicines use and consequently improve medication adherence, identify and solve drug related problems and enhance medication knowledge. Pharmacists, who are certified to provide the service, recognized the patients, who might need the service and invited them to participate in the study. The study consisted of two visits in 12 weeks' time period. Patients, who decided to participate, were randomly allocated in two groups - intervention and control. Both groups were interviewed and fulfilled questionnaires at visit 1 (V1). Afterwards the test group patients received PUZ. After 12 weeks both groups attended the visit 2 (V2), where they were re-interviewed and fulfilled questionnaires again. After the study completion also the patients from control group received PUZ due to ethical reasons.

Conditions

Interventions

TypeNameDescription
BEHAVIORALmedicines use reviewThe provision of MUR service as defined in the SOP MUR (Slovene Chamber of Pharmacies). It is classified as a type 2a review (PCNE typology) and it is intended for the patients to support them in regular and proper medicines use. MUR is performed based on medication history and information provided by the patient in a purposely scheduled conversation with the pharmacist. Pharmacists must be certified to provide MUR. MUR goal is to identify DRPs and recommend interventions to resolve them. During the MUR interview, the pharmacist completes a working sheet that records information regarding medicines, identified DRPs and recommended interventions. After the MUR interview, patients are provided with a personal medicines card that contains all the information that is needed to support effective and safe medicines use (dosing regimen, taking with/without food, special warnings, recommendations, etc.).

Timeline

Start date
2017-05-09
Primary completion
2017-09-16
Completion
2017-09-16
First posted
2020-06-04
Last updated
2020-06-04

Locations

14 sites across 1 country: Slovenia

Source: ClinicalTrials.gov record NCT04417400. Inclusion in this directory is not an endorsement.